Now I have all the information needed to produce the final review.

## Summary

This paper proposes HYPOGENEAGENT, an LLM-driven framework that uses annotation consistency as a criterion for selecting clustering resolution in single-cell/Perturb-seq data. Rather than treating functional annotation as a post-clustering step, the method feeds LLM-generated GO annotations back into resolution selection by computing intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD), combined into a Resolution Score. The paper systematically benchmarks LLM configurations on curated GOBP gene sets (Stage 1) and then applies a fixed configuration to a K562 CRISPRi Perturb-seq dataset (Stage 2), selecting resolutions r=0.4 (GEX) and r=0.5 (perturbation).

## Strengths

- **Novel formulation of resolution selection as an annotation-consistency problem.** Rather than treating functional annotation as a post-clustering step, HYPOGENEAGENT closes the loop by feeding annotation consistency back into resolution selection. This is a well-motivated conceptual step (Section 1, Section 3.4).

- **Clean, interpretable metric design.** The three metrics (ICS, ICD, Resolution Score) in Section 3.4 and Table 1 are clearly defined and directly map onto intuitive notions of cluster quality: good clusters should have a unified biological explanation that differs from neighboring clusters.

- **Systematic Stage-1 model selection.** The paper benchmarks multiple LLMs (GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, Gemini-2.5-pro), embedding methods (OpenAI, SapBERT, Nomic AI), prompt designs, and temperatures on curated GOBP gene sets before fixing a configuration for the main experiment (Section 4.2).

## Weaknesses

### Fatal
None.

### Major

- **No external ground truth for resolution selection.** The paper claims HYPOGENEAGENT selects biologically superior resolutions (Section 1: "alignment with known pathway"; Section 5: "exceeded traditional metrics"), but never defines what the "correct" resolution is for the K562 dataset or validates against known biological labels (e.g., pre-annotated cell types, validated perturbation categories). The Resolution Score peaks at r=0.4 (GEX) and r=0.5 (perturbation), while silhouette selects 0.5–0.6, modularity selects 0.7, and functional enrichment selects 0.4–0.5 — all nearby values. Without demonstrating that r=0.4 captures biological structure that r=0.5 or r=0.6 misses, the claimed superiority is unsubstantiated. This is the most serious weakness: the central claim that the method outperforms traditional metrics is not supported by the experiments as designed.

- **Single-dataset validation cannot support broad claims.** All experiments use only one dataset: K562 CRISPRi Perturb-seq (Replogle et al., 2022), from one cell line under one perturbation modality. The abstract, introduction, and conclusion make claims of general applicability ("general-purpose tool for single-cell, perturb-seq and multi-omics analyses," "paving the way for fully automated... pipelines"). The conclusion acknowledges generalizability as a limitation, but this does not retroactively validate the broad claims in earlier sections.

- **Framing of "objective" and "unbiased" is overstated.** The paper repeatedly calls the method "objective" (abstract, Sections 1 and 5) and "unbiased" (Section 4.4), but the Resolution Score depends entirely on an LLM whose outputs are sensitive to prompt phrasing, model version, temperature, and training data biases. The conclusion mentions "prompt sensitivity" as a limitation but provides no analysis. The paper also claims "calibrated confidence scores" (Section 3.3) without showing any calibration curves, reliability diagrams, or expected calibration error — this property is asserted, not demonstrated.

- **Comparison with traditional methods does not demonstrate superiority.** Section 4.4 criticizes silhouette and modularity for known theoretical weaknesses but never shows HYPOGENEAGENT's selected resolution avoids those weaknesses in practice. The functional enrichment comparison (Section 4.4.3) is circular: the paper applies the same ICS/ICD/RS metrics to enrichment-derived annotations and finds they agree with HYPOGENEAGENT's choice. This shows the metrics prefer similar resolutions regardless of annotation source, not that the selected resolution is biologically better.

### Minor

- **The hyperparameter w=1/3** is claimed to "give a stable ordering of resolutions across data sets" (Section 3.4), but only one Perturb-seq dataset was tested. The w sensitivity analysis (Figure S5) reveals inconsistent patterns across clusters, which the paper dismisses as "key clusters to be explored further" — this raises questions about robustness rather than resolving them.

- **No statistical significance testing.** The Resolution Score differences between adjacent resolutions (r=0.4 vs r=0.5) are not tested for significance. The box plots show overlapping distributions, making it unclear whether the selected resolution is genuinely distinguishable from its neighbors.

- **Unsubstantiated runtime claim.** The paper claims the pipeline is "orders of magnitude faster than manual curation" (Section 4.4) but provides no runtime, token counts, or API cost estimates. Running GPT-o3 on every cluster across 10 resolutions for multiple perturbation groups could be expensive; this claim is unverifiable as presented.

### Trivial
None.

## Nice-to-Haves

- Validate against a known ground truth on a multi-dataset benchmark with expert-annotated cell-type labels (e.g., PBMC, pancreas datasets), measuring whether the Resolution Score-maximizing partition better recovers known cell types (ARI/NMI) compared to silhouette-optimal or modularity-optimal partitions. This is the single highest-leverage experiment.
- Show that LLM annotations at the selected resolution are more accurate by external measure (e.g., the Stage-1 GOBP benchmark) than at other resolutions.
- Ablate the LLM component by replacing it with simpler baselines (e.g., Fisher-exact GO enrichment) to test whether the Resolution Score captures cluster quality rather than LLM output properties.
- Provide calibration curves or ECE for the claimed "calibrated confidence scores."
- Report cluster counts at each resolution across the full sweep.

## Removed Points

These points were flagged for removal; treat them with caution:
- "Grammatically broken sentence in abstract" — parser artifact, not an author error.
- "Method Section 3.2 missing clustering details" — paper refers to the appendix; appendix content is stripped by the parser.
- "Claim that existing methods 'ignore' biological interpretability is unfair" — the paper's characterization of classical metrics as biology-agnostic is factually accurate.
- "Stage 1 results all in appendix" — the paper does report key findings in the main text (e.g., AUC comparison, qualitative trends), and appendix figures are standard.
- "Related work section issues" — no external sources to verify; removed per guidelines.
- Various formatting/style nitpicks from section-by-section notes.

## Novel Insights

None beyond the paper's own contributions. The reviews surface a core tension between an interesting methodological idea and insufficient validation, but do not add analytical perspectives that the paper itself does not contain.

## Suggestions

1. Conduct multi-dataset validation with known cell-type ground truth (PBMC, pancreas, lung atlas subsets) and quantify how well the Resolution Score-maximizing partition recovers these labels compared to traditional metric-optimal partitions.
2. Tone down the framing: replace "objective" and "unbiased" with more precise language acknowledging the LLM dependence, and qualify the generalizability claims to match the single-dataset evidence.
3. Provide calibration evidence for the claimed "calibrated confidence scores."
4. Add statistical significance testing (permutation or bootstrap) for the selected resolution versus adjacent values.
5. Report computational cost (API calls, token counts, runtime) for the full pipeline.

## Score and Decision

The paper introduces a genuinely novel idea — using LLM-based annotation consistency for cluster resolution selection — with clean metric design and systematic LLM benchmarking. However, the empirical validation is fundamentally insufficient to support the central claims of biological superiority and general applicability. The four major weaknesses (no external ground truth, single-dataset design, overstated framing, uninformative comparison) all are verifiable from the paper as written and collectively undermine the paper's core claims. The promising idea does not compensate for the validation gap. Score reflects a borderline reject: the concept merits further development but the submission, as presented, does not provide adequate evidence for its claims.

MY FINAL SCORE: <score>4</score>
MY FINAL DECISION: <decision>Reject</decision>